載入...
The 13-Valent Pneumococcal Conjugate Vaccine Elicits Serological Response and Lasting Protection in Selected Patients With Primary Humoral Immunodeficiency
BACKGROUND: Patients with primary humoral immunodeficiency are more prone to invasive as well as recurrent pneumococcal infections. Therefore, anti-pneumococcal vaccination including the 13-valent conjugate vaccine is recommended. Nevertheless, to date, no data is available on immunogenicity of this...
Na minha lista:
| 發表在: | Front Immunol |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Frontiers Media S.A.
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8287634/ https://ncbi.nlm.nih.gov/pubmed/34290713 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.697128 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|